J.A. Kremer

432 total citations
4 papers, 339 citations indexed

About

J.A. Kremer is a scholar working on Rheumatology, Immunology and Genetics. According to data from OpenAlex, J.A. Kremer has authored 4 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Rheumatology, 3 papers in Immunology and 2 papers in Genetics. Recurrent topics in J.A. Kremer's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers) and Mast cells and histamine (1 paper). J.A. Kremer is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers) and Mast cells and histamine (1 paper). J.A. Kremer collaborates with scholars based in United States, United Kingdom and Austria. J.A. Kremer's co-authors include Lloyd Lininger, Emma Vernon, N Parhami, Anthony Sebba, Andrea Rubbert‐Roth, Ronald van Vollenhoven, M. C. Genovese, Marie Scully, Spero R. Cataland and Ara Metjian and has published in prestigious journals such as The Lancet, Annals of the Rheumatic Diseases and Hämostaseologie.

In The Last Decade

J.A. Kremer

4 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J.A. Kremer United States	3	204	91	81	76	58	4	339
MA Hull United Kingdom	6	178 0.9×	69 0.8×	118 1.5×	59 0.8×	28 0.5×	13	451
Sylviane Tardivel France	14	90 0.4×	52 0.6×	112 1.4×	37 0.5×	21 0.4×	38	429
Aktham Hassan France	5	168 0.8×	94 1.0×	120 1.5×	35 0.5×	9 0.2×	6	402
Jean‐Marie Frenoux France	9	83 0.4×	121 1.3×	121 1.5×	66 0.9×	12 0.2×	13	502
Karim Mowla Iran	11	112 0.5×	34 0.4×	80 1.0×	12 0.2×	139 2.4×	31	452
C. De Pascale United Kingdom	10	93 0.5×	105 1.2×	85 1.0×	31 0.4×	11 0.2×	15	366
Scott K. Reaves United States	12	190 0.9×	45 0.5×	110 1.4×	9 0.1×	19 0.3×	24	371
Samantha D. Pauls Canada	10	106 0.5×	25 0.3×	153 1.9×	94 1.2×	10 0.2×	17	416
M Brzeski United Kingdom	10	30 0.1×	51 0.6×	71 0.9×	22 0.3×	162 2.8×	14	346
H. Coetzer South Africa	8	379 1.9×	37 0.4×	149 1.8×	39 0.5×	24 0.4×	11	553

Countries citing papers authored by J.A. Kremer

Since Specialization

Citations

This map shows the geographic impact of J.A. Kremer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.A. Kremer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.A. Kremer more than expected).

Fields of papers citing papers by J.A. Kremer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.A. Kremer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.A. Kremer. The network helps show where J.A. Kremer may publish in the future.

Co-authorship network of co-authors of J.A. Kremer

This figure shows the co-authorship network connecting the top 25 collaborators of J.A. Kremer. A scholar is included among the top collaborators of J.A. Kremer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.A. Kremer. J.A. Kremer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Kremer, J.A., Marie Scully, Spero R. Cataland, et al.. (2019). Safety Results Normalized to Time of Exposure during the Phase 3 HERCULES Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura. Hämostaseologie. 39. 2 indexed citations

2.

Genovese, M. C., Anthony Sebba, Andrea Rubbert‐Roth, et al.. (2013). FRI0256 Long-term safety of tocilizumab in patients with rheumatoid arthritis following a mean treatment duration of 3.9 years. Annals of the Rheumatic Diseases. 72. A461–A461. 6 indexed citations

3.

Kremer, J.A., et al.. (1985). EFFECTS OF MANIPULATION OF DIETARY FATTY ACIDS ON CLINICAL MANIFESTATIONS OF RHEUMATOID ARTHRITIS. The Lancet. 325(8422). 184–187. 328 indexed citations

4.

Kremer, J.A., et al.. (1980). Relapsing polychondritis excellent response to naproxen and aspirin.. PubMed. 6(6). 719–20. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact